| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.59 | 0.004 | 0.744 | Rho-associated kinase inhibitor | 0.744 0.004 DBMET02043 | DBMET02043 | |
| 0.563 | 0.004 | 0.668 | Rho-associated kinase II inhibitor | 0.668 0.003 DBMET02043 | DBMET02043 | |
| 0.488 | 0.004 | 0.592 | Protein kinase A inhibitor | 0.592 0.004 DBMET02043 | DBMET02043 | |
| 0.462 | 0.004 | 0.654 | Protein kinase B gamma inhibitor | 0.654 0.003 DBMET02043 | DBMET02043 | |
| 0.352 | 0.116 | 0.352 | Calcium channel L-type activator | 0.345 0.121 DBMET02043 | ||
| 0.301 | 0.09 | 0.301 | Calcium channel activator | |||
| 0.245 | 0.037 | 0.253 | MAP kinase kinase 3 inhibitor | 0.253 0.029 DBMET02043 | DBMET02043 | |
| 0.165 | 0.016 | 0.165 | Protein kinase C delta inhibitor | 0.159 0.018 DBMET02043 | ||
| 0.179 | 0.033 | 0.179 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.159 0.057 DBMET02043 | ||
| 0.214 | 0.081 | 0.247 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.247 0.062 DBMET02043 | DBMET02043 | |
| 0.181 | 0.053 | 0.191 | Death-associated protein kinase 2 inhibitor | 0.191 0.042 DBMET02043 | DBMET02043 | |
| 0.318 | 0.189 | 0.318 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.3 0.212 DBMET02043 | ||
| 0.149 | 0.048 | 0.149 | Heat shock protein 70 antagonist | |||
| 0.135 | 0.043 | 0.135 | TRPA1 agonist | |||
| 0.115 | 0.023 | 0.219 | Rho-associated kinase I inhibitor | 0.219 0.008 DBMET02043 | DBMET02043 | |
| 0.154 | 0.063 | 0.223 | Hemostatic | 0.223 0.026 DBMET02043 | DBMET02043 | |
| 0.15 | 0.062 | 0.162 | Histone deacetylase SIRT1 inhibitor | 0.162 0.052 DBMET02043 | DBMET02043 | |
| 0.113 | 0.035 | 0.124 | Toll-Like receptor 3 antagonist | 0.124 0.027 DBMET02043 | DBMET02043 | |
| 0.209 | 0.135 | 0.209 | Gastrin inhibitor | |||
| 0.111 | 0.039 | 0.169 | Protein kinase C zeta inhibitor | 0.169 0.016 DBMET02043 | DBMET02043 | |
| 0.084 | 0.019 | 0.084 | Nitric oxide donor | 0.078 0.024 DBMET02043 | ||
| 0.131 | 0.078 | 0.138 | Death-associated protein kinase 1 inhibitor | 0.138 0.062 DBMET02043 | DBMET02043 | |
| 0.246 | 0.196 | 0.246 | MAP kinase kinase 6 inhibitor | 0.246 0.196 DBMET02043 | ||
| 0.112 | 0.068 | 0.112 | Interleukin 1b antagonist | |||
| 0.121 | 0.082 | 0.121 | Nav1.2 sodium channel blocker | |||
| 0.204 | 0.165 | 0.28 | Angiogenesis inhibitor | 0.28 0.103 DBMET02043 | DBMET02043 | |
| 0.063 | 0.024 | 0.086 | Factor IXa inhibitor | 0.086 0.014 DBMET02043 | DBMET02043 | |
| 0.136 | 0.106 | 0.16 | Protein kinase (CK1) gamma 3 inhibitor | 0.16 0.078 DBMET02043 | DBMET02043 | |
| 0.063 | 0.032 | 0.063 | Protein kinase C eta inhibitor | |||
| 0.074 | 0.044 | 0.126 | Protein kinase B alpha inhibitor | 0.126 0.016 DBMET02043 | DBMET02043 | |
| 0.07 | 0.044 | 0.079 | Protein kinase C alpha inhibitor | 0.079 0.034 DBMET02043 | DBMET02043 | |
| 0.195 | 0.169 | 0.211 | Cholesterol antagonist | 0.211 0.155 DBMET02043 | DBMET02043 | |
| 0.055 | 0.035 | 0.055 | Protein kinase C epsilon inhibitor | 0.051 0.04 DBMET02043 | ||
| 0.14 | 0.12 | 0.14 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.104 | 0.086 | 0.118 | Histone deacetylase class III inhibitor | 0.118 0.071 DBMET02043 | DBMET02043 | |
| 0.152 | 0.137 | 0.227 | Growth factor agonist | 0.227 0.043 DBMET02043 | DBMET02043 | |
| 0.144 | 0.132 | 0.189 | Death-associated protein kinase 3 inhibitor | 0.189 0.081 DBMET02043 | DBMET02043 | |
| 0.06 | 0.049 | 0.078 | Histone deacetylase SIRT3 inhibitor | 0.078 0.02 DBMET02043 | DBMET02043 | |
| 0.065 | 0.061 | 0.078 | Histone deacetylase SIRT2 inhibitor | 0.078 0.047 DBMET02043 | DBMET02043 | |
| 0.029 | 0.026 | 0.029 | Elastase 3B inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3A inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 2B inhibitor | |||
| 0.062 | 0.059 | 0.062 | Elastase 1 inhibitor | |||
| 0.111 | 0.109 | 0.132 | Protein kinase (CK1) gamma 1 inhibitor | 0.132 0.085 DBMET02043 | DBMET02043 | |
| 0.109 | 0.107 | 0.109 | Interleukin 1 antagonist | |||
| 0.085 | 0.084 | 0.085 | Interleukin 12 antagonist | |||
| 0.196 | 0.196 | 0.347 | Interleukin 2 agonist | 0.347 0.047 DBMET02043 | DBMET02043 | |
| 0.007 | 0.008 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.006 DBMET02043 | DBMET02043 | |
| 0.065 | 0.067 | 0.103 | Protein kinase B beta inhibitor | 0.103 0.024 DBMET02043 | DBMET02043 | |
| 0.124 | 0.13 | 0.224 | LIM domain kinase 1 inhibitor | 0.224 0.052 DBMET02043 | DBMET02043 | |
| 0.014 | 0.02 | 0.017 | Factor IX inhibitor | 0.017 0.014 DBMET02043 | DBMET02043 | |
| 0.093 | 0.106 | 0.159 | Cyclin-dependent kinase 7 inhibitor | 0.159 0.054 DBMET02043 | DBMET02043 | |
| 0.027 | 0.045 | 0.049 | Diamine oxidase inhibitor | 0.049 0.015 DBMET02043 | DBMET02043 | |
| 0.045 | 0.064 | 0.063 | Protein kinase C iota inhibitor | 0.063 0.038 DBMET02043 | DBMET02043 | |
| 0.026 | 0.049 | 0.038 | Factor VIIa inhibitor | 0.038 0.027 DBMET02043 | DBMET02043 | |
| 0.125 | 0.15 | 0.139 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.139 0.124 DBMET02043 | DBMET02043 | |
| 0.129 | 0.16 | 0.178 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.178 0.096 DBMET02043 | DBMET02043 | |
| 0.105 | 0.138 | 0.145 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.145 0.092 DBMET02043 | DBMET02043 | |
| 0.014 | 0.055 | 0.071 | Glucagon receptor antagonist | 0.071 0.006 DBMET02043 | DBMET02043 | |
| 0.079 | 0.12 | 0.143 | Protein kinase C gamma inhibitor | 0.143 0.036 DBMET02043 | DBMET02043 | |
| 0.116 | 0.158 | 0.137 | Interleukin antagonist | 0.137 0.128 DBMET02043 | DBMET02043 | |
| 0.072 | 0.123 | 0.134 | GABA receptor agonist | 0.134 0.045 DBMET02043 | DBMET02043 | |
| 0.089 | 0.144 | 0.145 | Protein kinase C nu inhibitor | 0.145 0.072 DBMET02043 | DBMET02043 | |
| 0.177 | 0.233 | 0.215 | Histamine release inhibitor | 0.215 0.186 DBMET02043 | DBMET02043 | |
| 0.084 | 0.145 | 0.119 | Interleukin 8 antagonist | 0.119 0.063 DBMET02043 | DBMET02043 | |
| 0.105 | 0.169 | 0.183 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.183 0.09 DBMET02043 | DBMET02043 | |
| 0.066 | 0.135 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 DBMET02043 | DBMET02043 | |
| 0.077 | 0.147 | 0.098 | CDC-like kinase 3 inhibitor | 0.098 0.084 DBMET02043 | DBMET02043 | |
| 0.143 | 0.216 | 0.206 | Peptidyltransferase inhibitor | 0.206 0.092 DBMET02043 | DBMET02043 | |
| 0.056 | 0.136 | 0.087 | Protein kinase C mu inhibitor | 0.087 0.071 DBMET02043 | DBMET02043 | |
| 0.221 | 0.303 | 0.323 | Antiinflammatory | 0.323 0.194 DBMET02043 | DBMET02043 | |
| 0.149 | 0.232 | 0.182 | Neuropeptide Y2 antagonist | 0.182 0.156 DBMET02043 | DBMET02043 | |
| 0.073 | 0.159 | 0.114 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.114 0.106 DBMET02043 | DBMET02043 | |
| 0.103 | 0.194 | 0.139 | MAP kinase 3 inhibitor | 0.139 0.087 DBMET02043 | DBMET02043 | |
| 0.103 | 0.196 | 0.145 | CF transmembrane conductance regulator agonist | 0.145 0.085 DBMET02043 | DBMET02043 | |
| 0.042 | 0.142 | 0.073 | I kappa B kinase 1 inhibitor | 0.073 0.044 DBMET02043 | DBMET02043 | |
| 0.053 | 0.154 | 0.083 | GABA B receptor agonist | 0.083 0.036 DBMET02043 | DBMET02043 | |
| 0.043 | 0.146 | 0.072 | Somatostatin 1 agonist | 0.072 0.062 DBMET02043 | DBMET02043 | |
| 0.187 | 0.294 | 0.279 | Cyclophilin D inhibitor | 0.279 0.182 DBMET02043 | DBMET02043 | |
| 0.119 | 0.23 | 0.211 | DNA damaging | 0.211 0.107 DBMET02043 | DBMET02043 | |
| 0.046 | 0.179 | 0.076 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.071 DBMET02043 | DBMET02043 | |
| 0.024 | 0.173 | 0.056 | Sphingosine 1-phosphate receptor 3 antagonist | 0.056 0.045 DBMET02043 | DBMET02043 | |
| 0.051 | 0.205 | 0.104 | Lanosterol 14 alpha demethylase inhibitor | 0.104 0.05 DBMET02043 | DBMET02043 | |
| 0.055 | 0.212 | 0.099 | Nav1.4 sodium channel blocker | 0.099 0.077 DBMET02043 | DBMET02043 | |
| 0.036 | 0.195 | 0.096 | Adrenaline agonist | 0.096 0.04 DBMET02043 | DBMET02043 | |
| 0.026 | 0.187 | 0.065 | Histone deacetylase inhibitor | 0.065 0.046 DBMET02043 | DBMET02043 | |
| 0.103 | 0.275 | 0.147 | Neurotensin receptor agonist | 0.147 0.109 DBMET02043 | DBMET02043 | |
| 0.079 | 0.257 | 0.204 | I kappa B kinase epsilon inhibitor | 0.204 0.068 DBMET02043 | DBMET02043 | |
| 0.119 | 0.321 | 0.211 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.211 0.145 DBMET02043 | DBMET02043 | |
| 0.049 | 0.265 | 0.092 | Carbonic anhydrase XV inhibitor | 0.092 0.079 DBMET02043 | DBMET02043 | |
| 0.037 | 0.256 | 0.122 | HIV-1 integrase (Overall Integration) inhibitor | 0.122 0.039 DBMET02043 | DBMET02043 | |
| 0.055 | 0.279 | 0.137 | Peroxidase inhibitor | 0.137 0.085 DBMET02043 | DBMET02043 | |
| 0.059 | 0.284 | 0.126 | MAP3K9 inhibitor | 0.126 0.102 DBMET02043 | DBMET02043 | |
| 0.064 | 0.291 | 0.124 | Hexokinase inhibitor | 0.124 0.113 DBMET02043 | DBMET02043 | |
| 0.061 | 0.291 | 0.142 | Anticonvulsant | 0.142 0.139 DBMET02043 | DBMET02043 | |
| 0.019 | 0.254 | 0.075 | Porphobilinogen synthase inhibitor | 0.075 0.051 DBMET02043 | DBMET02043 | |
| 0.097 | 0.333 | 0.14 | Cyclin-dependent kinase 3 inhibitor | 0.14 0.124 DBMET02043 | DBMET02043 | |
| 0.019 | 0.295 | 0.062 | I kappa B kinase 2 inhibitor | 0.062 0.043 DBMET02043 | DBMET02043 | |
| 0.024 | 0.304 | 0.088 | I kappa B kinase inhibitor | 0.088 0.05 DBMET02043 | DBMET02043 | |
| 0.05 | 0.346 | 0.159 | Cyclin-dependent kinase 8 inhibitor | 0.159 0.071 DBMET02043 | DBMET02043 | |
| 0.063 | 0.404 | 0.166 | Neurotrophic factor enhancer | 0.166 0.116 DBMET02043 | DBMET02043 | |
| 0.056 | 0.434 | 0.146 | Phospholipase C inhibitor | 0.146 0.115 DBMET02043 | DBMET02043 | |
| 0.029 | 0.42 | 0.164 | MAP kinase kinase 2 inhibitor | 0.164 0.109 DBMET02043 | DBMET02043 | |
| 0.091 | 0.494 | 0.183 | Nitric-oxide synthase stimulant | 0.183 0.122 DBMET02043 | DBMET02043 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |